Des-gamma-carboxy prothrombin and alpha-fetoprotein levels as biomarkers for hepatocellular carcinoma and their correlation with radiological characteristics

Table 1 Characteristics of study patients

Variables	Values
Age (yr)	58.5 ± 10.3
Gender: Males	146 (72.3)
Etiology
HCV	103 (51.0)
HBV	52 (25.7)
Alcohol	8 (4.0)
NAFLD	28 (13.9)
Autoimmune liver disease	7 (3.5)
Cryptogenic	9 (4.5)
Lab parameters
Hemoglobin (g/dL)	11.3 ± 2.1
White dell count (× 109/L)	8.3 ± 5.5
Platelets (× 109/L)	148.0 ± 102.0
Total bilirubin (mg/dL)	3.3 ± 5.6
Alanine aminotransferase (IU/L)	63.9 ± 51.4
Aspartate aminotransferase (IU/L)	113.0 ± 206.0
Alkaline phosphatase (IU/L)	203.0 ± 227.0
International normalization ratio	1.3 ± 0.4
Tumor parameters
HCC size 2 cm or more	156 (77.2)
HCC less than 2 cm	46 (22.8)
Portal vein thrombus	74 (36.6)
Unilobed	129 (63.9)
Bilobed	73 (36.1)
Satellite lesions	31 (15.3)
Multicentric tumor	127 (62.9)
Des-gamma carboxyprothrombin (mAU/L)	669.4 (16.7-300000.0)
Alpha-fetoprotein (ng/mL)	32 (1-20000)

Values are mean ± SD or n (%).

HCV: Hepatitis C virus; HBV: Hepatitis B virus; NAFLD: Non-alcoholic fatty liver disease; HCC: Hepatocellular carcinoma.